Observational Study to Evaluate Health Status of Chronic Obstructive Pulmonary Disease (COPD) Patients in Response to Real-life Treatments in Thailand
1 other identifier
observational
684
1 country
20
Brief Summary
The purpose of this study is to evaluate health status of uncontrolled Chronic Obstructive Pulmonary Disease (COPD) patients in response to treatments in clinical practice.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2010
20 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2010
CompletedFirst Submitted
Initial submission to the registry
July 23, 2010
CompletedFirst Posted
Study publicly available on registry
July 26, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2012
CompletedMay 31, 2012
May 1, 2012
1.7 years
July 23, 2010
May 30, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in PEF and overall CCQ score
between the first visit and after 12 (plus or minus 1) weeks
Secondary Outcomes (1)
Difference of the changes of PEF and overall CCQ score comparing between various treatments
between the first visit and after 12 (plus or minus 1) weeks
Eligibility Criteria
Primary care and Specialty care in 20 centers nationwide in Thailand
You may qualify if:
- Provision of informed consent prior to any study specific procedures
- Male or non-pregnant female aged \>40 years
- A clinical diagnosis of COPD with FEV1/ FVC \<0.70 and require combination or modified therapy
- Smoke \> 10 Pack Year
You may not qualify if:
- Involvement in the planning and/or conduct of the study (applies to both AstraZeneca staff and/or staff at the study site)
- Participation in a clinical study (precluding non-interventional study or registry) during the last 3 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- AstraZenecalead
Study Sites (20)
Research Site
SaiMai, Bangkok, Thailand
Research Site
Watana, Bangkok, Thailand
Research Site
Maung, Changwat Chanthaburi, Thailand
Research Site
Maung, Changwat Chiang Rai, Thailand
Research Site
Muang, Changwat Chon Buri, Thailand
Research Site
Muang, Changwat Khon Kaen, Thailand
Research Site
Ongkharak, Changwat Nakhon Nayok, Thailand
Research Site
Maung, Changwat Nonthaburi, Thailand
Research Site
Muang, Changwat Phitsanulok, Thailand
Research Site
Maung, Changwat Rayong, Thailand
Research Site
Hat Yai, Changwat Songkhla, Thailand
Research Site
Song Phi Nong, Changwat Suphan Buri, Thailand
Research Site
Maung, Changwat Trang, Thailand
Research Site
Maung, Chiang Mai, Thailand
Research Site
Maung, Nakhon Sri Thammarat, Thailand
Research Site
Maung, Nakhonratchasima, Thailand
Research Site
Maung, Nakhonsawan, Thailand
Research Site
Maung, Phuket, Thailand
Research Site
Maung, Sakolnakorn, Thailand
Research Site
Prannok, Bangkok, Thailand
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Assoc. Prof. Watchara Boonsawat
Khon Kaen University
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 23, 2010
First Posted
July 26, 2010
Study Start
July 1, 2010
Primary Completion
March 1, 2012
Study Completion
March 1, 2012
Last Updated
May 31, 2012
Record last verified: 2012-05